Transaction · 0001193125-26-418101

KASINGER JAMES R.

KASINGER JAMES R., GC, SECY, reported a transaction classified as exercise at CRISPR Therapeutics AG involving 1990.000000 shares for an estimated $0.00. Reported holdings after the transaction were 81242.000000 shares. The stored filing text includes a detected 10b5-1 reference.

exerciseSEC transaction code MGC, SECY
CRSPCRISPR Therapeutics AG
Filing timeOct 08
Trade dateOct 06, 2026
Filing · SECView on SEC
InsiderProfile
% of reported position tradedUnavailableNot calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$50.44
Pre-filing
1mo ago1w ago +11.0%1d ago +13.7%
Returns since
7d30d90d180d1y

CRSP price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
CRSP since 2026-10-08Filed yesterday · 1 day of post-filing data
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
exercise
Code M
Identifier
0001193125-26-418101
Stock Option (Right to Buy)
Transaction date
Oct 06, 2026
Filed Oct 08, 2026, 09:35 PM · 2d delay
Shares
1.99k sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
81.2k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction Direct Ownership 10b5-1 Detected
-16score
Filing-only score

-16

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

General Counsel and Secretary

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 6, 2026.

  2. F2

    The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.00 to $60.08, inclusive. The reporting person undertakes to provi…

  3. F3

    This option was granted on May 31, 2017 with respect to 123,000 Common Shares of which 25% shall vest on May 31, 2018 and the remaining 75% shall vest monthly thereafter for 36 months.

Original filing · 0001193125-26-418101
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

CRSP